APA (7th ed.) Citation

Härtel, N., Hanfstein, B., Müller, M. C., & Erben, P. (2012). Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: A potential mechanism of altered leukemogenicity. Journal of cancer research and clinical oncology, 138(2), . https://doi.org/10.1007/s00432-011-1086-x

Chicago Style (17th ed.) Citation

Härtel, Nicolai, Benjamin Hanfstein, Martin Christian Müller, and Philipp Erben. "Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing Cells: A Potential Mechanism of Altered Leukemogenicity." Journal of Cancer Research and Clinical Oncology 138, no. 2 (2012). https://doi.org/10.1007/s00432-011-1086-x.

MLA (9th ed.) Citation

Härtel, Nicolai, et al. "Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing Cells: A Potential Mechanism of Altered Leukemogenicity." Journal of Cancer Research and Clinical Oncology, vol. 138, no. 2, 2012, https://doi.org/10.1007/s00432-011-1086-x.